Uterine Corpus Neoplasm — Trials

Uterine Corpus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,714 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07316361	GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer(GYNORYLAQ™)	enrolling by invitation	Early Phase 1	40	Biogenea Pharmaceuticals Ltd.INDUSTRY	1	Jan 7, 2026	clinicaltrials

Data updated 23 days agoSource updated Jan 7, 2026source: clinicaltrials